Erin Wright
Stock Analyst at Morgan Stanley
(4.49)
# 300
Out of 5,131 analysts
245
Total ratings
64.74%
Success rate
14.37%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Equal-Weight | $277 → $262 | $276.85 | -5.36% | 5 | Dec 18, 2025 | |
| ELV Elevance Health | Maintains: Equal-Weight | $359 → $352 | $372.83 | -5.59% | 5 | Dec 18, 2025 | |
| ELAN Elanco Animal Health | Maintains: Equal-Weight | $18 → $22 | $23.47 | -6.26% | 12 | Dec 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $89 → $93 | $80.30 | +15.82% | 7 | Dec 10, 2025 | |
| ZTS Zoetis | Maintains: Overweight | $211 → $175 | $127.17 | +37.61% | 8 | Nov 10, 2025 | |
| MCK McKesson | Maintains: Overweight | $857 → $916 | $816.06 | +12.25% | 10 | Nov 6, 2025 | |
| HSIC Henry Schein | Maintains: Underweight | $55 → $58 | $77.64 | -25.30% | 5 | Nov 5, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Overweight | $765 → $805 | $713.35 | +12.85% | 19 | Nov 4, 2025 | |
| ALGN Align Technology | Maintains: Equal-Weight | $142 → $154 | $172.79 | -10.87% | 25 | Oct 30, 2025 | |
| OPCH Option Care Health | Initiates: Overweight | $35 | $31.80 | +10.06% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $163 → $204 | $181.50 | +12.40% | 3 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $32 | $37.53 | -14.73% | 4 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $128 → $140 | $142.16 | -1.52% | 2 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $23.63 | -28.06% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $313 → $330 | $335.69 | -1.70% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $181 → $190 | $201.11 | -5.52% | 12 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $39.44 | -34.08% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $278.95 | +39.81% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $3.32 | -3.61% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $12.78 | +79.97% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $174.44 | -1.40% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $343.98 | +70.65% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $251.81 | +19.14% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $12.41 | +238.44% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $238.37 | +20.82% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $220.91 | +59.34% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $3.93 | +1,019.59% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $595.00 | -69.58% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $67.56 | -74.84% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $32.17 | +276.13% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $618.86 | -6.28% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $9.33 | +275.13% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $181.38 | +13.02% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $27.85 | -60.50% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $242.41 | -35.23% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $542.92 | -43.27% | 1 | Oct 25, 2017 |
Humana
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $277 → $262
Current: $276.85
Upside: -5.36%
Elevance Health
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $359 → $352
Current: $372.83
Upside: -5.59%
Elanco Animal Health
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $18 → $22
Current: $23.47
Upside: -6.26%
CVS Health
Dec 10, 2025
Maintains: Overweight
Price Target: $89 → $93
Current: $80.30
Upside: +15.82%
Zoetis
Nov 10, 2025
Maintains: Overweight
Price Target: $211 → $175
Current: $127.17
Upside: +37.61%
McKesson
Nov 6, 2025
Maintains: Overweight
Price Target: $857 → $916
Current: $816.06
Upside: +12.25%
Henry Schein
Nov 5, 2025
Maintains: Underweight
Price Target: $55 → $58
Current: $77.64
Upside: -25.30%
IDEXX Laboratories
Nov 4, 2025
Maintains: Overweight
Price Target: $765 → $805
Current: $713.35
Upside: +12.85%
Align Technology
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $142 → $154
Current: $172.79
Upside: -10.87%
Option Care Health
Oct 17, 2025
Initiates: Overweight
Price Target: $35
Current: $31.80
Upside: +10.06%
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $163 → $204
Current: $181.50
Upside: +12.40%
Oct 14, 2025
Maintains: Overweight
Price Target: $25 → $32
Current: $37.53
Upside: -14.73%
Oct 3, 2025
Maintains: Equal-Weight
Price Target: $128 → $140
Current: $142.16
Upside: -1.52%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $23.63
Upside: -28.06%
Jul 16, 2025
Maintains: Equal-Weight
Price Target: $313 → $330
Current: $335.69
Upside: -1.70%
Jul 16, 2025
Maintains: Overweight
Price Target: $181 → $190
Current: $201.11
Upside: -5.52%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $39.44
Upside: -34.08%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $278.95
Upside: +39.81%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $3.32
Upside: -3.61%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $12.78
Upside: +79.97%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $174.44
Upside: -1.40%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $343.98
Upside: +70.65%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $251.81
Upside: +19.14%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $12.41
Upside: +238.44%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $238.37
Upside: +20.82%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $220.91
Upside: +59.34%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $3.93
Upside: +1,019.59%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $595.00
Upside: -69.58%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $67.56
Upside: -74.84%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $32.17
Upside: +276.13%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $618.86
Upside: -6.28%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $9.33
Upside: +275.13%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $181.38
Upside: +13.02%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $27.85
Upside: -60.50%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $242.41
Upside: -35.23%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $542.92
Upside: -43.27%